ELDN

NASDAQStock

Eledon Pharmaceuticals, Inc.

$2.69-0.03 (-1.16%)

52-Week Range

$1.39

$4.36

Key Stats

Market Cap

161.2M

P/E Ratio

10.75

Dividend Yield

—

Beta

0.96

Volume

500.1K

Avg Volume

1.2M

Performance

+35.32%

+65.85%

+10.57%

YTD

+67.90%

-25.48%

+35.32%

-80.49%

Price Chart

ETF Exposure

ELDN is held by 35 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.03%	150,423	$415K	$1.27B	0.60%
IWN	iShares Russell 2000 Value ETF	0.01%	458,370	$1.3M	$12.21B	0.24%
VTWV	Vanguard Russell 2000 Value ETF	0.01%	38,107	$84K	$1.00B	0.06%
SC0K.DE	Invesco Russell 2000 UCITS ETF	0.01%	0	$0	$189.7M	0.45%
IWM	iShares Russell 2000 ETF	0.01%	1,374,533	$3.8M	$69.44B	0.19%
RESM	Columbia Research Enhanced Small Cap ETF	0.01%	55	$151	$3.1M	0.32%
XSU.TO	iShares U.S. Small Cap Index ETF (CAD-Hedged)	0.01%	1,374,533	$37K	$677.7M	0.36%
RSSL	Global X - Russell 2000 ETF	0.00%	26,299	$60K	$1.33B	0.08%
UWM	ProShares - Ultra Russell2000	0.00%	3,341	$9K	$264.2M	1.07%
VTWO	Vanguard Russell 2000 ETF	0.00%	267,245	$588K	$14.50B	0.06%
URTY	ProShares - UltraPro Russell2000	0.00%	3,358	$9K	$284.9M	1.08%
R2SC.L	State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)	0.00%	60,847	$95K	$3.73B	0.30%
VXF	Vanguard Extended Market ETF	0.00%	811,675	$1.8M	$84.10B	0.05%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	4,749	$13K	$2.36B	0.25%
HDG	ProShares - Hedge Replication ETF	0.00%	63	$171	$23.2M	0.95%
IWO	iShares Russell 2000 Growth ETF	0.00%	39,833	$110K	$12.36B	0.24%
SMMD	iShares Russell 2500 ETF	0.00%	20,615	$57K	$2.28B	0.23%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	17,419	$47K	$40.55B	0.17%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$13	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	16	$44	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	27	$75	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	31	$86	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	37	$102	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	31	$85	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	20	$56	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	15	$42	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	7	$18	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	115	$345	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	4,138	$12K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	20	$59	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	4,266	$9K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	2,356,062	$5.2M	$2.10T	0.03%
VTWG	Vanguard Russell 2000 Growth ETF	0.00%	3,062	$7K	$1.50B	0.06%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	12,392	$37K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,068	$3K	$1.29B	0.17%

About ELDN ETF Exposure

Eledon Pharmaceuticals, Inc. (ELDN) is held by 35 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 161.2M, ELDN is a widely held institutional stock. The stock currently trades at $2.69. Investors can gain exposure to ELDN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ELDN, sorted by portfolio weight.